InfuSystems Holdings (STU:1TZ) Cyclically Adjusted Revenue per Share: €4.93 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1TZ InfuSystems Holdings Inc STU:1TZ
30 GF Score
Price €10.60
GF Value €8.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is InfuSystems Holdings Cyclically Adjusted Revenue per Share?

InfuSystems Holdings STU:1TZ +2.91% 30 Cyclically Adjusted Revenue per Share is €4.93 as of Jun. 2026. GuruFocus rates STU:1TZ with a GF Score™ of 30/100 and a GF Value™ of €8.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

InfuSystems Holdings's adjusted revenue per share for the three months ended in Jun. 2026 was €1.532. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €4.93 for the trailing ten years ended in Jun. 2026.

During the past 12 months, InfuSystems Holdings's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of InfuSystems Holdings was 10.30% per year. The lowest was 3.80% per year. And the median was 8.40% per year.

As of today (2026-08-10), InfuSystems Holdings's current stock price is €10.60. InfuSystems Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €4.93. InfuSystems Holdings's Cyclically Adjusted PS Ratio of today is 2.15.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of InfuSystems Holdings was 6.41. The lowest was 0.46. And the median was 1.74.


InfuSystems Holdings  (STU:1TZ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

InfuSystems Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.60/4.93
=2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of InfuSystems Holdings was 6.41. The lowest was 0.46. And the median was 1.74.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


InfuSystems Holdings Cyclically Adjusted Revenue per Share Related Terms


InfuSystems Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for InfuSystems Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InfuSystems Holdings Cyclically Adjusted Revenue per Share Chart

InfuSystems Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 4.51 4.46

InfuSystems Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.31 4.39 4.46 4.72 4.93

STU:1TZ vs LUCD, QTRX, QSI: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, InfuSystems Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Cyclically Adjusted PS Ratio falls into.


STU:1TZ
30GF Score
InfuSystems Holdings Inc STU:1TZ
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InfuSystems Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InfuSystems Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.532/333.9520*333.9520
=1.532

Current CPI (Jun. 2026) = 333.9520.

InfuSystems Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.667 241.428 0.923
201612 0.706 241.432 0.977
201703 0.728 243.801 0.997
201706 0.663 244.955 0.904
201709 0.648 246.819 0.877
201712 0.701 246.524 0.950
201803 0.585 249.554 0.783
201806 0.619 251.989 0.820
201809 0.691 252.439 0.914
201812 0.790 251.233 1.050
201903 0.822 254.202 1.080
201906 0.848 256.143 1.106
201909 0.944 256.759 1.228
201912 0.894 256.974 1.162
202003 0.979 258.115 1.267
202006 1.067 257.797 1.382
202009 0.985 260.280 1.264
202012 0.925 260.474 1.186
202103 0.937 264.877 1.181
202106 0.934 271.696 1.148
202109 1.097 274.310 1.336
202112 1.057 278.802 1.266
202203 1.179 287.504 1.369
202206 1.243 296.311 1.401
202209 1.284 296.808 1.445
202212 1.119 296.797 1.259
202303 1.360 301.836 1.505
202306 1.356 305.109 1.484
202309 1.377 307.789 1.494
202312 1.340 306.746 1.459
202403 1.387 312.332 1.483
202406 1.442 314.175 1.533
202409 1.470 315.301 1.557
202412 1.489 315.605 1.576
202503 1.520 319.799 1.587
202506 1.482 322.561 1.534
202509 1.484 324.800 1.526
202512 1.481 324.054 1.526
202603 1.395 330.213 1.411
202606 1.532 333.952 1.532

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €4.93 mean?
InfuSystems Holdings (STU:1TZ) has a Cyclically Adjusted Revenue per Share of €4.93 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on InfuSystems Holdings and its competitors.
Is InfuSystems Holdings' Cyclically Adjusted Revenue per Share too high?
InfuSystems Holdings' current Cyclically Adjusted Revenue per Share is €4.93. Overall, InfuSystems Holdings has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Cyclically Adjusted Revenue per Share compare to LUCD and QTRX?
InfuSystems Holdings' Cyclically Adjusted Revenue per Share of €4.93 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on InfuSystems Holdings and its competitors. InfuSystems Holdings's current Cyclically Adjusted Revenue per Share is €4.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (STU:1TZ) is currently considered Significantly Overvalued. The stock's GF Value™ is €8.10, compared to a current price of €10.60 — trading 30.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €4.93. InfuSystems Holdings' overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For InfuSystems Holdings (STU:1TZ), the current Cyclically Adjusted Revenue per Share is €4.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InfuSystems Holdings (STU:1TZ) Overvalued in 2026?

Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued. The current stock price of €10.60 is trading 30.9% above its estimated GF Value™ of €8.10. GuruFocus considers InfuSystems Holdings to be Significantly Overvalued.

Key valuation signals for STU:1TZ:

  • Cyclically Adjusted Revenue per Share: €4.93
  • GF Value™: €8.10 vs. price of €10.60 (30.9% above fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the STU:1TZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InfuSystems Holdings Business Description

Other Exchanges INFU:USA1TZ:Germany
Address 3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
30GF Score

Get the complete analysis for STU:1TZ

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.60
Price
€8.10
GF Value